UBXD8 promotes lung cancer progression and activates the HIF-1α pathway
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.UBXD8 protein promotes non-small cell lung cancer (NSCLC) growth and spread by stabilizing hypoxia-inducible factor 1-alpha (HIF-1α). Reducing UBXD8 levels inhibits tumor progression and impacts lipid metabolism.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- UBXD8 (ubiquitin regulatory X domain-containing protein 8) is upregulated in advanced cancers.
- High UBXD8 expression correlates with poor patient survival rates.
Purpose Of The Study
- To investigate the role of UBXD8 in non-small cell lung cancer (NSCLC) progression.
- To elucidate the molecular mechanisms underlying UBXD8's function in cancer.
Main Methods
- Knockdown of UBXD8 in NSCLC cell lines and xenograft models.
- Analysis of cell proliferation, migration, and tumor growth.
- Investigation of hypoxia-inducible factor (HIF) signaling pathways.
- Metabolic analysis focusing on lipid profiles.
Main Results
- UBXD8 knockdown significantly reduced NSCLC cell proliferation and migration in vitro.
- Tumor growth was suppressed in xenograft models lacking UBXD8.
- UBXD8 was identified as a positive regulator of HIF-1α protein stabilization and expression.
- Absence of UBXD8 led to increased levels of unsaturated fatty acids, indicating a role in lipid metabolism.
Conclusions
- UBXD8 plays a critical role in NSCLC development and progression.
- UBXD8 influences tumor growth through modulation of HIF-1α signaling.
- UBXD8 is involved in regulating cellular lipid metabolism.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...